Incidence, clinical characteristics and risk factors for infantile hemangioma ulceration after oral propranolol initiation: A retrospective study
Journal of the American Academy of Dermatology · 2026
DOI: 10.1016/j.jaad.2026.06.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Academy of Dermatology, 2026. Verfasst von Kaizhi Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Oncology, Department of Pediatric Surgery, West China Hospital of Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Propranolol, Skin Ulcer, Skin Neoplasms, Adrenergic beta-Antagonists. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Science Foundation for Excellent Youth Scholars of Sichuan University, Sichuan University West China Hospital.
Abstract (Originalsprache)
BACKGROUND: Some patients with infantile hemangioma (IH) still develop ulcerations during oral propranolol, but these IH ulcerations have not been systematically studied. OBJECTIVE: To analyze the incidence, clinical features and risk factors associated with IH ulceration after oral propranolol initiation. METHODS: Retrospective study at one tertiary referral center. RESULTS: We evaluated 470 patients with IH who received oral propranolol and 51 patients with nonintervention IH ulceration; 24 (5.1%) developed IH ulceration during oral propranolol. The median age at the discovery of IH ulceration was 3.9 months in the IH ulceration group after oral propranolol initiation, which was significantly later than the 2.0 months in the nonintervention IH ulceration group (P = .013). Multivariate analysis revealed that mixed IH (odds ratio [OR] = 5.620; 95% confidence interval [CI]: 1.419-22.265), indeterminate IH (OR = 8.219; 95% CI: 1.560-43.305), and segmental IH (OR = 22.806; 95% CI: 2.157-241.028) were independent risk factors for IH ulceration after oral propranolol initiation. Conversely, IH on the trunk (OR = 0.063, 95% CI: 0.007-0.580) and extremity (OR = 0.016, 95% CI: 0.001-0.289) were protective factors. LIMITATIONS: This was a single-center retrospective study. CONCLUSIONS: This study reports the incidence of IH ulceration in patients who received oral propranolol and identifies risk factors associated with IH ulceration after oral propranolol initiation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Oncology, Department of Pediatric Surgery, West China Hospital of Sichuan University, Chengdu, China.
- Division of Oncology, Department of Pediatric Surgery, West China Hospital of Sichuan University, Chengdu, China. Electronic address: jijiyuanyuan@163.com.
Förderung
- National Natural Science Foundation of China
- Science Foundation for Excellent Youth Scholars of Sichuan University
- Sichuan University West China Hospital
- Sichuan University
Zitieren
APA
Zhang, K., Qiu, T., Gong, X., Zhou, J., Yang, L., Han, Y., Lan, Y., Zhang, Y., & Ji, Y. (2026). Incidence, clinical characteristics and risk factors for infantile hemangioma ulceration after oral propranolol initiation: A retrospective study. Journal of the American Academy of Dermatology. https://doi.org/10.1016/j.jaad.2026.06.005
Vancouver
Zhang K, Qiu T, Gong X, Zhou J, Yang L, Han Y, et al. Incidence, clinical characteristics and risk factors for infantile hemangioma ulceration after oral propranolol initiation: A retrospective study. Journal of the American Academy of Dermatology. 2026. doi:10.1016/j.jaad.2026.06.005
BibTeX
@article{Zhang2026,
author = {Zhang, Kaizhi and Qiu, Tong and Gong, Xue and Zhou, Jiangyuan and Yang, Linyu and Han, Yunyan and Lan, Yuru and Zhang, Yunhan and Ji, Yi},
title = {Incidence, clinical characteristics and risk factors for infantile hemangioma ulceration after oral propranolol initiation: A retrospective study},
journal = {Journal of the American Academy of Dermatology},
year = {2026},
doi = {10.1016/j.jaad.2026.06.005}
}
EUVIMED